Manisha Koirala was diagnosed with stage IV ovarian cancer in 2012. She later made a recovery after undergoing treatment in ...

In a recent clip, Dr Jackson-Spence shared a number of different symptoms that could actually be something more serious - ...

A cancer survivor is raising awareness about the importance of genetic testing. Why she believes it can be imperative to ...

In this video, Ursula A. Matulonis, MD, discusses new data on rinatabart sesutecan, or Rina-S, for patients with advanced ovarian cancer, which were presented at Society of Gynecologic Oncology Annual ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

In this video, Ursula A. Matulonis, MD, shares that although data from the REFRaME-O1 trial of luveltamab tazevibulin were presented at Society of Gynecologic Oncology Annual Meeting on Women’s Cancer ...

The addition of bevacizumab to first-line (1L) chemotherapy offers real-world benefit to patients with epithelial ovarian cancer with high-risk prognostic factors.

A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune responses and resist immunotherapies.

ERNA-101 remains on track for IND-enabling studies in 2025, with first-in-human studies targeted for 2026.

What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...

In an exclusive conversation with Filmfare, veteran actress Manisha Koirala opened up about her journey through mental health ...

In March 2025, Aprea entered into a Material Transfer Agreement (MTA) with MD Anderson Cancer Center. Aprea has agreed to supply APR-1051 to support preclinical research aimed at exploring its ...